Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Death; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number SE-MPA-2021-021283. Other case identifier number SE-MPA-1616072349251. An 83-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular in Mar2021 (Batch/Lot Number: EP 2166) as 0.3 mL, single for COVID-19 immunization. Medical history included metastatic uterine cancer with unspecified localization. There were no concomitant medications. The patient died in Mar2021 at home, seven days after her first dose of Comirnaty. It was unknown if an autopsy was performed. Outcome: Fatal. Report assessed as serious, death. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166